Lab Matters Fall 2017 | Page 15

partner profile to participants. Risk communication can be challenging when different languages and cultures are involved. In these cases, we have to have consent forms and other materials translated into culturally acceptable languages. At a time when science is being relegated to a secondary position in policy circles, how can APHL and CDC help the newly launched National Biomonitoring Network grow a nd flourish? There are often unanticipated complications when conducting field- based studies. We once had to delay a project because customs in the Dominican Republic impounded our sampling equipment. In another study, we suspended hair sample collection from children in East Baltimore because many of the children had hair so short we couldn’t collect it. Another study involved communities in India that had a religious prohibition against cutting hair. So obviously it was unacceptable to collect hair samples from them. The first thing is to better communicate the need for exposure characterization in addressing health concerns about existing and emerging hazardous exposures. In addition, we need to be prepared to address a wide range of possible exposures that might arise from an emergency or terrorist event. We can’t possibly deal with the environmental challenges of the day without high-quality laboratory capacity. As NCEH/ATSDR director, you have been involved in high-profile environmental health investigations. How important is biomonitoring in such situations? Our goal is to prevent exposures from happening. But if they do happen, the goal shifts to assessing the extent of the exposure. In many cases, biomonitoring plays an important role in this assessment. Lead is a perfect example. We wouldn’t have been able to characterize the risks during the Flint, Michigan, water crisis if we didn’t have blood lead levels and national reference blood lead data from biomonitoring. PublicHealthLabs @APHL Formalizing the National Biomonitoring Network is critical to expanding laboratory capacity to deal with the myriad of exposure challenges we face today. We hope to broaden the use of high-quality biomonitoring to increase state’s ability to conduct routine surveillance, support health investigations and respond to emergencies. We want biomonitoring to be more readily available, so we can improve the quality of exposure and health assessments. What are your ultimate goals for environmental health? How can people limit their exposure to environmental toxicants? We all face potentially hazardous environmental exposures in our homes, our workplaces and the communities we live in. There are often simple things we can all do to reduce or eliminate hazardous exposures in our everyday lives. But in order to do this, we must be better informed about the sources of exposure, the routes of exposure (i.e., how they get into our bodies) and the potential impacts. For example, if you have a house built before 1978, you are at risk for lead-based paint exposure. As a result, you should not renovate without taking precautions like keeping your child away from any repair work that disturbs paint and hiring a qualified contractor to do the work. In addition, you should consult with your pediatrician about blood lead monitoring to assure your children are safe. If you have asbestos in your house, simply knowing where it is, and not disturbing it, can be extremely important. Knowledge is power; knowing what’s in your environment and how you might be exposed can take you a long way down the path of minimizing your exposure and reducing any possible health effects. If there are easy things you can do to lower your exposure, do them. This is prudent public health practice. ■ The overall goal is to anticipate, identify and prevent hazardous exposures in order to improve health and wellbeing. To do that, we need to know how and when hazardous exposures occur. This work requires a wide range of expertise, including toxicologists, clinicians, epidemiologists, engineers and chemists. APHL.org Fall 2017 LAB MATTERS 13